Elbe-Kliniken Stade-Buxtehude GmbH

Buxtehude 21614

0 studies enrolling now · 2 studies all time

What they study most

Advanced Melanoma, Coronary Artery Disease

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma. — Completed
• The Dual Antiplatelet Therapy Study (DAPT Study) — Completed